Pulmonx Cost of Goods Sold 2019-2024 | LUNG
Pulmonx cost of goods sold from 2019 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
| Pulmonx Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $18 |
| 2022 | $14 |
| 2021 | $13 |
| 2020 | $12 |
| 2019 | $10 |
| 2018 | $8 |
| Pulmonx Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-06-30 | $5 |
| 2024-03-31 | $5 |
| 2023-12-31 | $5 |
| 2023-09-30 | $5 |
| 2023-06-30 | $4 |
| 2023-03-31 | $4 |
| 2022-12-31 | $4 |
| 2022-09-30 | $3 |
| 2022-06-30 | $4 |
| 2022-03-31 | $3 |
| 2021-12-31 | $3 |
| 2021-09-30 | $4 |
| 2021-06-30 | $3 |
| 2021-03-31 | $3 |
| 2020-12-31 | $3 |
| 2020-09-30 | $3 |
| 2020-06-30 | $3 |
| 2020-03-31 | $3 |
| 2019-12-31 | |
| 2019-09-30 | $3 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.294B | $0.069B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.384B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.892B | 183.76 |
| Hims & Hers Health (HIMS) | United States | $5.028B | 130.06 |
| Axonics (AXNX) | United States | $3.600B | 1760.50 |
| IRhythm Technologies (IRTC) | United States | $2.707B | 0.00 |
| Enovis (ENOV) | United States | $2.594B | 17.58 |
| Privia Health (PRVA) | United States | $2.547B | 213.00 |
| Omnicell (OMCL) | United States | $2.306B | 75.97 |
| Azenta (AZTA) | United States | $2.190B | 124.39 |
| 10x Genomics (TXG) | United States | $1.893B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.696B | 0.00 |
| Schrodinger (SDGR) | United States | $1.365B | 0.00 |
| Phreesia (PHR) | United States | $1.228B | 0.00 |
| Standard BioTools (LAB) | United States | $0.800B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.589B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.558B | 0.00 |
| Talkspace (TALK) | United States | $0.555B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.500B | 84.80 |
| Health Catalyst (HCAT) | United States | $0.498B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.230B | 0.00 |
| TruBridge (TBRG) | United States | $0.203B | 58.91 |
| American Well (AMWL) | United States | $0.135B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.108B | 0.00 |
| HeartBeam (BEAT) | United States | $0.068B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.045B | 0.00 |
| CareCloud (CCLD) | United States | $0.044B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Movano (MOVE) | United States | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |